{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:26:28Z","timestamp":1781173588444,"version":"3.54.1"},"reference-count":64,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>FAT10 expression is highly up-regulated by pro-inflammatory cytokines IFN\u03b3 and TNF\u03b1 in all cell types and tissues. Increased FAT10 expression may induce increasing mitotic non-disjunction and chromosome instability, leading to tumorigenesis. In this review, we summarized others\u2019 and our work on FAT10 expression in liver biopsy samples from patients with alcoholic hepatitis (AH). FAT10 is essential to maintain the function of liver cell protein quality control and Mallory\u2013Denk body (MDB) formation. FAT10 overexpression in AH leads to balloon degeneration and MDB aggregation formation, all of which is prevented in fat10-\/- mice. FAT10 causes the proteins\u2019 accumulation, overexpression, and forming MDBs through modulating 26s proteasome\u2019s proteases. The pathway that increases FAT10 expression includes TNF\u03b1\/IFN\u03b3 and the interferon sequence response element (ISRE), followed by NF\u03baB and STAT3, which were all up-regulated in AH. FAT10 was only reported in human and mouse specimens but plays critical role for the development of alcoholic hepatitis. Flavanone derivatives of milk thistle inhibit TNF\u03b1\/IFN\u03b3, NF\u03baB, and STAT3, then inhibit the expression of FAT10. NF\u03baB is the key nodal hub of the IFN\u03b1\/TNF\u03b1-response genes. Studies on Silibinin and other milk thistle derivatives to treat AH confirms that overexpressed FAT10 is the major key molecule in these networks.<\/jats:p>","DOI":"10.3390\/biomedicines8070189","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T02:44:25Z","timestamp":1593657865000},"page":"189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of FAT10 in Alcoholic Hepatitis Pathogenesis"],"prefix":"10.3390","volume":"8","author":[{"given":"Yue","family":"Jia","sequence":"first","affiliation":[{"name":"Harbor-UCLA Medical Center, Torrance, CA 90509, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ji","sequence":"additional","affiliation":[{"name":"Harbor-UCLA Medical Center, Torrance, CA 90509, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"French","sequence":"additional","affiliation":[{"name":"Harbor-UCLA Medical Center, Torrance, CA 90509, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2015.11.006","article-title":"Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths","volume":"644","author":"Sheron","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0676.1989.tb00399.x","article-title":"Alcohol and liver injury: Dose-related or permissive effect?","volume":"9","year":"1989","journal-title":"Liver"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tibs.2008.01.005","article-title":"Activating the ubiquitin family: UBA6 challenges the field","volume":"33","author":"Groettrup","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1073\/pnas.96.8.4313","article-title":"A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/sj.onc.1206337","article-title":"Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers","volume":"22","author":"Lee","year":"2003","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1038\/onc.2008.201","article-title":"Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon","volume":"27","author":"Lukasiak","year":"2008","journal-title":"Oncogene"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y","article-title":"A ubiquitin-like protein which is synergistically inducible by interferon-\u03b3 and tumor necrosis factor-\u03b1","volume":"29","author":"Raasi","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.molonc.2014.01.007","article-title":"NF\u03baB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53","volume":"8","author":"Choi","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2010.04.001","article-title":"The role of cytokines in UBD promoter regulation and Mallory-Denk body-like aggresomes","volume":"89","author":"Oliva","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biocel.2016.07.001","article-title":"The ubiquitin-like modifier FAT10 in cancer development","volume":"79","author":"Aichem","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Liu, S., Jin, Y., Zhang, D., Wang, J., Wang, G., and Lee, C.G.L. (2018). Investigating the promoter of FAT10 gene in HCC patients. Genes, 9.","DOI":"10.3390\/genes9070319"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wang, F., and Zhan, B. (2019). UBA6 and its bispecific pathways for ubiquitin and FAT10. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092250"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2018.02.007","article-title":"GRP78 promoter hepatocellular carcinoma proliferation by increasing FAT10 expression through the NF\u03baB pathway","volume":"365","author":"Luo","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.yexmp.2012.09.002","article-title":"FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse model","volume":"93","author":"French","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"ref_15","unstructured":"Kurtovic, E., and Limaiem, F. (2020). Mallory Bodies. 30 Jul 2019. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.3748\/wjg.v17.i17.2172","article-title":"Mallory-Denk Bodies in chronic hepatitis","volume":"17","author":"Basaranoglu","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.yexcr.2007.04.024","article-title":"From Mallory to Mallory-Denk bodies: What, how and why?","volume":"313","author":"Zatloukal","year":"2007","journal-title":"Exp. Cell Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.yexmp.2010.03.001","article-title":"SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model","volume":"88","author":"Oliva","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.yexmp.2016.03.010","article-title":"The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"100","author":"French","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yexmp.2008.11.002","article-title":"Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms","volume":"86","author":"Oliva","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yexmp.2014.10.001","article-title":"Mallory-Denk body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic Steatohepatitis","volume":"97","author":"Liu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4254\/wjh.v2.i8.295","article-title":"Mallory-Denk body pathogenesis revisited","volume":"2","author":"French","year":"2010","journal-title":"World J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e18517","DOI":"10.1371\/journal.pone.0018517","article-title":"Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis","volume":"6","author":"Lemaire","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e48587","DOI":"10.1371\/journal.pone.0048587","article-title":"Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1074\/jbc.M109.065920","article-title":"A novel LZAP-binding protein, NLBP, inhibits cell invasion","volume":"285","author":"Kwon","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1038\/emboj.2010.116","article-title":"Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity","volume":"29","author":"Shiwaku","year":"2010","journal-title":"EMBO J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.4161\/cc.25451","article-title":"Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation","volume":"12","author":"Kim","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ramadori, P., Cubero, F.J., Liedtke, C., Trautwein, C., and Nevzorova, Y.A. (2017). Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame. Cancers, 9.","DOI":"10.3390\/cancers9100130"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15943","DOI":"10.3748\/wjg.v20.i43.15943","article-title":"Alcohol and hepatocellular carcinoma: A review and a point of view","volume":"20","author":"Testino","year":"2014","journal-title":"World. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cld.2012.08.001","article-title":"Prevalence and natural history of alcoholic liver disease","volume":"16","author":"Schwartz","year":"2012","journal-title":"Clin. Liver Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/gut.2003.019984","article-title":"Affiliations Long term prognosis of fatty liver: Risk of chronic liver disease and death","volume":"53","author":"Franzmann","year":"2004","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/gut.51.1.132","article-title":"Cocarcinogenic effects of alcohol in hepatocarcinogenesis","volume":"51","author":"Stickel","year":"2002","journal-title":"Gut"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-319-09614-8_7","article-title":"Alcoholic cirrhosis and hepatocellular carcinoma","volume":"815","author":"Stickel","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.febslet.2009.01.006","article-title":"Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L","volume":"583","author":"Schmidtke","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ncomms1752","article-title":"FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis","volume":"3","author":"Rani","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/MCB.25.9.3483-3491.2005","article-title":"FAT10, a ubiquitin-independent signal for proteasomal degradation","volume":"25","author":"Hipp","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexmp.2007.12.003","article-title":"Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis","volume":"84","author":"Oliva","year":"2008","journal-title":"Exp. Mol. Pathol."},{"key":"ref_40","first-page":"174","article-title":"Alcoholic liver disease-Hepatocellular carcinoma transformation","volume":"3","author":"French","year":"2012","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yexmp.2018.07.005","article-title":"Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH)","volume":"105","author":"Jia","year":"2018","journal-title":"Exp. Mol. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc.2016.143","article-title":"SUMO and the robustness of cancer","volume":"17","author":"Seeler","year":"2017","journal-title":"Nat. Rev. Cancer."},{"key":"ref_43","first-page":"1081","article-title":"The Post-Translational Modification, SUMOylation, and Cancer (Review)","volume":"52","author":"Hao","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1096\/fj.201701124R","article-title":"SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease","volume":"32","author":"Tomasi","year":"2018","journal-title":"FASEB J."},{"key":"ref_45","first-page":"1","article-title":"The ubiquitin-like modifier FAT10 interferes with SUMO activation","volume":"10","author":"Annette","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yexmp.2015.09.009","article-title":"FAT10 suppression stabilizes oxidized proteins in liver cells: Effects of HCV and ethanol","volume":"99","author":"Ganesan","year":"2015","journal-title":"Exp. Molec. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.yexmp.2011.01.004","article-title":"The immunoproteasome in steatohepatitis: Its role in Mallory-Denk body formation","volume":"90","author":"French","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/carcin\/bgt407","article-title":"FAT10, an Ubiquitin-like Protein, Confers Malignant Properties in Non-tumorigenic and Tumorigenic Cells","volume":"35","author":"Gao","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexmp.2010.09.005","article-title":"Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms","volume":"90","author":"Qing","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bjc.6605870","article-title":"Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery","volume":"103","author":"Yan","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yexmp.2014.07.001","article-title":"TLR3\/4 signaling is mediated via the NF\u03baB-CXCR4\/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies","volume":"97","author":"Liu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yexmp.2014.05.010","article-title":"Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form","volume":"97","author":"Liu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E5282","DOI":"10.1073\/pnas.1403383111","article-title":"Disruption of FAT10-MAD2 binding inhibits tumor progression","volume":"111","author":"Theng","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamcr.2013.01.009","article-title":"FAT10ylation as a signal for proteasomal degradation","volume":"1843","author":"Schmidtke","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/emboj\/19.1.94","article-title":"Recognition of thepolyubiquitin proteolytic signal","volume":"19","author":"Thrower","year":"2000","journal-title":"EMBO J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1091\/mbc.e11-07-0609","article-title":"FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination","volume":"23","author":"Buchsbaum","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yexmp.2017.09.001","article-title":"The role of Tec Kinase signalling pathways in the development of Mallory-Denk bodies in balloon cells in alcoholic hepatitis","volume":"103","author":"Afifiyan","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yexmp.2017.01.011","article-title":"Over expression of proteins that alter the intracellular signaling pathways in the cytoplasm of the liver cells forming Mallory-Denk bodies","volume":"102","author":"Afifiyan","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29881","article-title":"Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis","volume":"68","author":"Qu","year":"2018","journal-title":"Hepatology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1681\/ASN.2009050479","article-title":"The Ubiquitin-Like Protein FAT10 Mediates NF-\u03baB Activation","volume":"21","author":"Gong","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molimm.2019.11.004","article-title":"IFN\u03b3\u2009potentiates TNF\u03b1\/TNFR1 signaling to induce FAT10 expression in macrophages","volume":"117","author":"Gueta","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1128\/MCB.00966-05","article-title":"FAT10\/diubiquitin-like Protein-Deficient Mice Exhibit Minimal Phenotypic Differences","volume":"26","author":"Allon","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejmech.2016.07.070","article-title":"Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer-A comprehensive review","volume":"123","author":"Polachi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Gao, Y., Theng, S.S., Mah, W.C., and Lee, C.G. (2015). Silibinin down-regulates FAT10 and modulate TNF\u03b1\/IFN\u03b3-induced chromosomal instability and apoptosis sensitivity. Co. Biol., 1\u20139.","DOI":"10.1242\/bio.011189"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/7\/189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:45:45Z","timestamp":1760175945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/7\/189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["biomedicines8070189"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8070189","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}